Literature DB >> 33597771

Simple and reliable detection of CRISPR-induced on-target effects by qgPCR and SNP genotyping.

Isabel Weisheit1,2, Joseph A Kroeger1,2, Rainer Malik1, Benedikt Wefers3,4, Peter Lichtner5, Wolfgang Wurst3,4,6,7, Martin Dichgans1,3,7, Dominik Paquet8,9,10.   

Abstract

The recent CRISPR revolution has provided researchers with powerful tools to perform genome editing in a variety of organisms. However, recent reports indicate widespread occurrence of unintended CRISPR-induced on-target effects (OnTEs) at the edited site in mice and human induced pluripotent stem cells (iPSCs) that escape standard quality controls. By altering gene expression of targeted or neighbouring genes, OnTEs can severely affect phenotypes of CRISPR-edited cells and organisms and thus lead to data misinterpretation, which can undermine the reliability of CRISPR-based studies. Here we describe a broadly applicable framework for detecting OnTEs in genome-edited cells and organisms after non-homologous end joining-mediated and homology-directed repair-mediated editing. Our protocol enables identification of OnTEs such as large deletions, large insertions, rearrangements or loss of heterozygosity (LOH). This is achieved by subjecting genomic DNA first to quantitative genotyping PCR (qgPCR), which determines the number of intact alleles at the target site using the same PCR amplicon that has been optimized for genotyping. This combination of genotyping and quantitation makes it possible to exclude clones with monoallelic OnTEs and hemizygous editing, which are often mischaracterized as correctly edited in standard Sanger sequencing. Second, occurrence of LOH around the edited locus is detected by genotyping neighbouring single-nucleotide polymorphisms (SNPs), using either a Sanger sequencing-based method or SNP microarrays. All steps are optimized to maximize simplicity and minimize cost to promote wide dissemination and applicability across the field. The entire protocol from genomic DNA extraction to OnTE exclusion can be performed in 6-9 d.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33597771     DOI: 10.1038/s41596-020-00481-2

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  36 in total

Review 1.  Biology and Applications of CRISPR Systems: Harnessing Nature's Toolbox for Genome Engineering.

Authors:  Addison V Wright; James K Nuñez; Jennifer A Doudna
Journal:  Cell       Date:  2016-01-14       Impact factor: 41.582

2.  Quantifying CRISPR off-target effects.

Authors:  Soragia Athina Gkazi
Journal:  Emerg Top Life Sci       Date:  2019-05-31

3.  Large deletions induced by Cas9 cleavage.

Authors:  Fatwa Adikusuma; Sandra Piltz; Mark A Corbett; Michelle Turvey; Shaun R McColl; Karla J Helbig; Michael R Beard; James Hughes; Richard T Pomerantz; Paul Q Thomas
Journal:  Nature       Date:  2018-08-08       Impact factor: 49.962

Review 4.  Development and applications of CRISPR-Cas9 for genome engineering.

Authors:  Patrick D Hsu; Eric S Lander; Feng Zhang
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

Review 5.  Cornerstones of CRISPR-Cas in drug discovery and therapy.

Authors:  Christof Fellmann; Benjamin G Gowen; Pei-Chun Lin; Jennifer A Doudna; Jacob E Corn
Journal:  Nat Rev Drug Discov       Date:  2016-12-23       Impact factor: 84.694

Review 6.  Technologies and Computational Analysis Strategies for CRISPR Applications.

Authors:  Kendell Clement; Jonathan Y Hsu; Matthew C Canver; J Keith Joung; Luca Pinello
Journal:  Mol Cell       Date:  2020-07-02       Impact factor: 17.970

7.  Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements.

Authors:  Michael Kosicki; Kärt Tomberg; Allan Bradley
Journal:  Nat Biotechnol       Date:  2018-07-16       Impact factor: 54.908

Review 8.  CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes.

Authors:  Alexis C Komor; Ahmed H Badran; David R Liu
Journal:  Cell       Date:  2016-11-17       Impact factor: 41.582

9.  Microhomologies are prevalent at Cas9-induced larger deletions.

Authors:  Dominic D G Owens; Adam Caulder; Vincent Frontera; Joe R Harman; Alasdair J Allan; Akin Bucakci; Lucas Greder; Gemma F Codner; Philip Hublitz; Peter J McHugh; Lydia Teboul; Marella F T R de Bruijn
Journal:  Nucleic Acids Res       Date:  2019-08-22       Impact factor: 16.971

10.  CRISPR/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome.

Authors:  Ha Youn Shin; Chaochen Wang; Hye Kyung Lee; Kyung Hyun Yoo; Xianke Zeng; Tyler Kuhns; Chul Min Yang; Teresa Mohr; Chengyu Liu; Lothar Hennighausen
Journal:  Nat Commun       Date:  2017-05-31       Impact factor: 14.919

View more
  4 in total

1.  Loss of TREM2 rescues hyperactivation of microglia, but not lysosomal deficits and neurotoxicity in models of progranulin deficiency.

Authors:  Anika Reifschneider; Sophie Robinson; Bettina van Lengerich; Johannes Gnörich; Todd Logan; Steffanie Heindl; Miriam A Vogt; Endy Weidinger; Lina Riedl; Karin Wind; Artem Zatcepin; Ida Pesämaa; Sophie Haberl; Brigitte Nuscher; Gernot Kleinberger; Julien Klimmt; Julia K Götzl; Arthur Liesz; Katharina Bürger; Matthias Brendel; Johannes Levin; Janine Diehl-Schmid; Jung Suh; Gilbert Di Paolo; Joseph W Lewcock; Kathryn M Monroe; Dominik Paquet; Anja Capell; Christian Haass
Journal:  EMBO J       Date:  2022-01-12       Impact factor: 11.598

2.  A Single Transcript Knockdown-Replacement Strategy Employing 5' UTR Secondary Structures to Precisely Titrate Rescue Protein Translation.

Authors:  Matthew M Millette; Elizabeth D Holland; Tanner J Tenpas; Erik W Dent
Journal:  Front Genome Ed       Date:  2022-03-28

3.  TPC2 rescues lysosomal storage in mucolipidosis type IV, Niemann-Pick type C1, and Batten disease.

Authors:  Anna Scotto Rosato; Einar K Krogsaeter; Dawid Jaślan; Carla Abrahamian; Sandro Montefusco; Chiara Soldati; Barbara Spix; Maria Teresa Pizzo; Giuseppina Grieco; Julia Böck; Amanda Wyatt; Daniela Wünkhaus; Marcel Passon; Marc Stieglitz; Marco Keller; Guido Hermey; Sandra Markmann; Doris Gruber-Schoffnegger; Susan Cotman; Ludger Johannes; Dennis Crusius; Ulrich Boehm; Christian Wahl-Schott; Martin Biel; Franz Bracher; Elvira De Leonibus; Elena Polishchuk; Diego L Medina; Dominik Paquet; Christian Grimm
Journal:  EMBO Mol Med       Date:  2022-08-05       Impact factor: 14.260

4.  Homozygous might be hemizygous: CRISPR/Cas9 editing in iPSCs results in detrimental on-target defects that escape standard quality controls.

Authors:  Dina Simkin; Vasileios Papakis; Bernabe I Bustos; Christina M Ambrosi; Steven J Ryan; Valeriya Baru; Luis A Williams; Graham T Dempsey; Owen B McManus; John E Landers; Steven J Lubbe; Alfred L George; Evangelos Kiskinis
Journal:  Stem Cell Reports       Date:  2022-03-10       Impact factor: 7.294

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.